https://pipelinereview.com/FibroGen-Announces-Results-for-MATTERHORN-a-Phase-3-Clinical-Study-of-Roxadustat-for-the-Treatment-of-Anemia-in-Patients-with-Myelodysplastic-Syndromes-MDS/